Mountain Capital Investment Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-4,911
Closed -$793K 58
2023
Q4
$793K Sell
4,911
-417
-8% -$63.9K 0.27% 32
2023
Q3
$785K Sell
5,328
-4,327
-45% -$714K 0.29% 30
2023
Q2
$1.65M Sell
9,655
-2,712
-22% -$438K 0.62% 27
2023
Q1
$2.05M Buy
12,367
+1,189
+11% +$192K 0.91% 35
2022
Q4
$1.96M Buy
11,178
+2,178
+24% +$376K 0.89% 41
2022
Q3
$1.48M Buy
9,000
+254
+3% +$43K 0.78% 42
2022
Q2
$1.56M Buy
8,746
+232
+3% +$41.3K 0.78% 42
2022
Q1
$1.53M Sell
8,514
-131
-2% -$22.3K 0.72% 48
2021
Q4
$1.48M Buy
8,645
+1,758
+26% +$288K 0.67% 52
2021
Q3
$1.11M Buy
6,887
+168
+3% +$28.7K 0.59% 64
2021
Q2
$1.14M Sell
6,719
-899
-12% -$149K 0.52% 56
2021
Q1
$1.22M Buy
7,618
+1,120
+17% +$181K 0.61% 54
2020
Q4
$1.04M Sell
6,498
-1,250
-16% -$184K 0.63% 49
2020
Q3
$1.18M Buy
+7,748
New +$1.15M 0.76% 47
2017
Q4
Sell
-937
Closed -$122K 231
2017
Q3
$122K Buy
937
+2
+0.2% +$265 0.11% 52
2017
Q2
$124K Buy
+935
New +$119K 0.12% 64

Other funds holding JNJ

Mountain Capital Investment Advisors's JNJ Position: Q1 2024 in Review

Mountain Capital Investment Advisors sold out of Johnson & Johnson (JNJ) in Q1 2024, closing a stake of 4,911 shares — an estimated $793K sold.

Mountain Capital Investment Advisors first reported a position in JNJ in Q2 2017 and held it in 16 quarters. The position peaked at $2.05M in Q1 2023. 3,849 funds tracked by Wall St. Rank hold JNJ as of Q1 2024.

  • Mountain Capital Investment Advisors reported no remaining Johnson & Johnson position as of Q1 2024 after selling out during the quarter.
  • Mountain Capital Investment Advisors sold 4,911 Johnson & Johnson shares in Q1 2024, an estimated $793K.
  • Mountain Capital Investment Advisors first reported a position in Johnson & Johnson in Q2 2017 and held it in 16 quarters.
  • Mountain Capital Investment Advisors's Johnson & Johnson position peaked at $2.05M in Q1 2023.
  • 3,849 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2024.

Based on Mountain Capital Investment Advisors's 13F filing for Q1 2024, filed 11 Apr 2024.